Bezafibrate, a fibric acid derivative known for its capability to attenuate the progression of IR in CAD patients [109] and the declining of beta cells function in T2DM [110] has been reported to enhance adiponectin levels, partly acting through PPAR alpha stimulation [111]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.